Who are the new decision makers in medicines management? What’s the impact on your products and what new funding mechanisms are in place to support new therapies?
If you know the answers to these questions, then you probably don’t need to attend our Medicines and Money half-day event on 20 April.
If you’re in doubt, we can help. We have experts on hand to answer your questions and to advise on the best approaches to navigating these uncharted routes to prescribing across the new NHS structures now being implemented in England.
Ben Woodhouse, head of medicines optimisation and prescribing lead at Bolton CCG will be explaining the changes to funding for medicines and accountable care, as well as looking at new budgetary models and capitated funding.
Our very own Steve How has a passion for driving quality and outcomes improvements that are designed around patients. Having worked in the pharmaceutical industry, he has extensive experience in NHS partnership projects and improved service redesign.
During the session, Steve will provide an overview of the prescribing landscape and the new stakeholders. Together, you’ll explore what the new structures mean ‘in the real world’. How are medicines management teams working towards efficiency targets? What prescribing decision support software is out there and who’s using it?
The Medicines and Money seminar is the ideal opportunity to fast track your understanding of the new prescribing landscape and ensure that you know who your customers are, what their challenges will be, and then most importantly, how you can provide the appropriate support to overcome them.
Can you afford to miss out on this invaluable market insight? Find further information, or book your place now.